A systematic review evaluating AFP (at a threshold level of 20 ng/mL) in cirrhotic patients showed sensitivities and specificities of 41% to 65% and 80% to 94%, respectively, for HCC at any stage [30]. The gene discussed is AFP; the disease is hepatocellular carcinoma.